Paxman AB (PAX) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Poor Management Efficiency with a low ROE of 5.08%

The company has been able to generate a Return on Equity (avg) of 5.08% signifying low profitability per unit of shareholders funds

With ROE of 1.97%, it has a very expensive valuation with a 3.56 Price to Book Value

Below par performance in long term as well as near term

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

SEK 1,503 Million (Small Cap)

P/E

180.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.31

Return on Equity

1.97%

Price to Book

3.53

Revenue and Profits:

Net Sales:

75 Million

(Quarterly Results - Jun 2025)

Net Profit:

-3 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-13.31%

6 Months

-13.31%

1 Year

17.4%

2 Years

86.05%

3 Years

12.45%

4 Years

0.36%

5 Years

88.55%

Paxman AB for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

25.45%

EBIT Growth (5y)

88.17%

EBIT to Interest (avg)

0.01

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.52

Sales to Capital Employed (avg)

1.28

Tax Ratio

6.01%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

9.10%

ROE (avg)

5.08%

Valuation key factors

Factor

Value

P/E Ratio

180

Industry P/E

Price to Book Value

3.56

EV to EBIT

62.21

EV to EBITDA

35.94

EV to Capital Employed

4.71

EV to Sales

5.08

PEG Ratio

Dividend Yield

ROCE (Latest)

7.57%

ROE (Latest)

1.97%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 11.62% vs 1.36% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 40.00% vs -145.08% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "74.90",
          "val2": "67.10",
          "chgp": "11.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5.00",
          "val2": "10.40",
          "chgp": "-51.92%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3.70",
          "val2": "11.70",
          "chgp": "-68.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-3.30",
          "val2": "-5.50",
          "chgp": "40.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "7.70%",
          "val2": "92.40%",
          "chgp": "-8.47%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 20.42% vs 44.00% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 384.34% vs 180.58% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "253.00",
          "val2": "210.10",
          "chgp": "20.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "47.60",
          "val2": "29.10",
          "chgp": "63.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.10",
          "val2": "1.30",
          "chgp": "-15.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "40.20",
          "val2": "8.30",
          "chgp": "384.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "132.40%",
          "val2": "60.10%",
          "chgp": "7.23%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

74.90

67.10

11.62%

Operating Profit (PBDIT) excl Other Income

5.00

10.40

-51.92%

Interest

3.70

11.70

-68.38%

Exceptional Items

0.00

Consolidate Net Profit

-3.30

-5.50

40.00%

Operating Profit Margin (Excl OI)

7.70%

92.40%

-8.47%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is 11.62% vs 1.36% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 40.00% vs -145.08% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

253.00

210.10

20.42%

Operating Profit (PBDIT) excl Other Income

47.60

29.10

63.57%

Interest

1.10

1.30

-15.38%

Exceptional Items

0.00

Consolidate Net Profit

40.20

8.30

384.34%

Operating Profit Margin (Excl OI)

132.40%

60.10%

7.23%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 20.42% vs 44.00% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 384.34% vs 180.58% in Dec 2023

All Annual Results

Company CV

About Paxman AB

Paxman AB

Pharmaceuticals & Biotechnology

Paxman AB (publ) is a Sweden-based developer of scalp cooling technology. The cooling system aims to reduce the risk of hair loss connected with cytostatic treatment of cancer. The Company offers a stand-alone, mobile electric cooling unit, which markets under the name Paxman Scalp Cooler, which is a liquid-based cooling system that cools down the patients scalp through the silicone hat. The product has two versions - for one or two patients to be cooled at once. Each device contains a built-in touch screen with a menu-controlled graphic user interface to monitor the process. The lightweight system enables patient to participate in other activities. The Company’s primary markets are Great Britain, Scandinavian countries, the Netherlands, Belgium and Australia.

Company Coordinates

Company Details

Pirgatan 13 , KARLSHAMN None : 374 35

Tel:

http://www.paxman.se/

Registrar Details